Applied Therapeutics Inc (APLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APLT | AMGN | VRTX | BMY | GILD |
| Company | Applied Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 9.01 | 291.50 | 478.56 | 58.16 | 91.71 |
| High | 9.10 | 291.50 | 479.94 | 58.36 | 91.99 |
| Low | 8.67 | 279.62 | 458.10 | 56.01 | 88.56 |
| Last | 8.70 | 284.04 | 462.04 | 55.90 | 88.45 |
| Change | -0.31 | -11.89 | -21.92 | -2.60 | -3.66 |
| % Change | -3.44% | -4.02% | -4.53% | -4.44% | -3.97% |
| Volume | 1,373,148 | 3,614,711 | 1,574,259 | 14,881,324 | 5,759,909 |
| 20-Day Average Volume | 1,792,718 | 2,422,018 | 1,141,189 | 11,177,147 | 7,027,868 |
| Previous Close | 9.01 | 295.93 | 483.96 | 58.50 | 92.11 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 9.18 | 313.99 | 482.94 | 54.91 | 90.71 |
| 20-Day Raw Stochastic | 18.03% | 9.93% | 5.54% | 47.96% | 25.00% |
| 20-Day Relative Strength | 51.42% | 28.82% | 43.58% | 56.65% | 51.63% |
| Weighted Alpha | +88.32 | -0.75 | +22.99 | +18.66 | +24.71 |
| Today's Opinion | 80% Buy | 40% Sell | 16% Buy | 100% Buy | 80% Buy |
| Previous Opinion | 80% Buy | 40% Sell | 72% Buy | 100% Buy | 96% Buy |
| Last Month's Opinion | 100% Buy | 24% Buy | 56% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -13.18% since 11/08/24 | -12.55% since 11/08/24 | -10.69% since 11/08/24 | +3.91% since 11/08/24 | -7.91% since 11/08/24 |
| Low | 8.67 on 11/15/24 | 279.62 on 11/15/24 | 458.10 on 11/15/24 | 56.15 on 11/15/24 | 88.56 on 11/15/24 |
| High | 10.62 on 11/11/24 | 327.58 on 11/11/24 | 518.35 on 11/11/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 1-Month | |||||
| %Chg | -4.16% since 10/15/24 | -12.50% since 10/15/24 | -4.70% since 10/15/24 | +6.63% since 10/15/24 | +3.62% since 10/15/24 |
| Low | 8.35 on 10/29/24 | 279.62 on 11/15/24 | 458.10 on 11/15/24 | 51.81 on 10/28/24 | 85.60 on 10/22/24 |
| High | 10.62 on 11/11/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +47.97% since 08/15/24 | -12.58% since 08/15/24 | -2.22% since 08/15/24 | +14.55% since 08/15/24 | +19.62% since 08/15/24 |
| Low | 4.55 on 09/16/24 | 279.62 on 11/15/24 | 447.70 on 10/07/24 | 46.88 on 08/22/24 | 72.89 on 08/16/24 |
| High | 10.62 on 11/11/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +99.09% since 05/15/24 | -10.84% since 05/15/24 | +5.49% since 05/15/24 | +26.27% since 05/15/24 | +32.70% since 05/15/24 |
| Low | 3.95 on 05/23/24 | 279.62 on 11/15/24 | 432.22 on 05/16/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 10.62 on 11/11/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,048,368 | 159,072,144 | 124,633,728 | 118,648,352 | 114,793,560 |
| Shares Outstanding, K | 116,356 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 9,990,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -119,760,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 120,000 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -68,590,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 2.01 | 0.60 | 0.39 | 0.44 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.20 on 11/07/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/14/24 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.68 | 0.00 | 49.92 | 20.91 |